Clincosm LogoSign in Get a demo

acute lymphoblastic leukemia

Showing NaN - NaN of 41
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (procedure, drug,

Not yet recruiting
  • Acute Leukemia of Ambiguous Lineage
  • +8 more
  • Biospecimen Collection
  • +12 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 22, 2023

Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative Trial in Worldwide (procedure,

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +15 more
  • Birmingham, Alabama
  • +550 more
Jan 28, 2023

Cancer Care Delivery in Adolescent and Young Adult Acute

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • Discussion
  • +2 more
  • Anchorage, Alaska
  • +481 more
Jan 25, 2023

Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

Suspended
  • Juvenile Myelomonocytic Leukemia
  • +27 more
  • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 11, 2023

Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Aurora, Seattle (drug, procedure,

Active, not recruiting
  • Acute Biphenotypic Leukemia
  • +18 more
  • Aurora, Colorado
  • +2 more
Dec 28, 2022

Acute Lymphoblastic Leukemia Trial in United States (Calaspargase pegol (S95015))

Recruiting
  • Acute Lymphoblastic Leukemia
  • Calaspargase pegol (S95015)
  • Scottsdale, Arizona
  • +14 more
Dec 13, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma Trial in Seattle (Allogeneic Hematopoietic

Recruiting
  • Acute Lymphoblastic Leukemia
  • +16 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 1, 2022

Acute Erythroid Leukemia, Acute Lymphoblastic Leukemia, Acute Megakaryoblastic Leukemia Trial in United States (drug, radiation,

Recruiting
  • Acute Erythroid Leukemia
  • +10 more
  • San Francisco, California
  • +5 more
Nov 1, 2022

Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (procedure, drug, biological, radiation)

Recruiting
  • Acute Leukemia
  • +18 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 26, 2022

Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia Trial in Worldwide (procedure,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +3 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +21 more
  • Birmingham, Alabama
  • +219 more
Sep 15, 2022

Participated in Children's Oncology Group Studies

Recruiting
  • Acute Lymphoblastic Leukemia
  • +5 more
  • Assessment of Therapy Complications
  • Questionnaire Administration
  • Birmingham, Alabama
  • +163 more
Sep 6, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia

Recruiting
  • Acute Lymphoblastic Leukemia
  • +11 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 29, 2022

Acute Biphenotypic Leukemia, Acute Leukemia, Acute Leukemia of Ambiguous Lineage Trial in United States (radiation, drug,

Recruiting
  • Acute Biphenotypic Leukemia
  • +11 more
  • Total-Body Irradiation
  • +8 more
  • Los Angeles, California
  • +9 more
Aug 19, 2022

Acute Lymphoblastic Leukemia Trial in United States (Everolimus, Prednisone, Vincristine)

Completed
  • Acute Lymphoblastic Leukemia
  • San Francisco, California
  • +7 more
Aug 5, 2022

Acute Lymphoblastic Leukemia, Lymphoblastic Leukemia Trial in Canada, United States (IM JZP-458, IV JZP-458)

Completed
  • Acute Lymphoblastic Leukemia
  • Lymphoblastic Leukemia
  • IM JZP-458
  • IV JZP-458
  • Birmingham, Alabama
  • +73 more
Aug 3, 2022

Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Seattle (drug, other, biological)

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • Lymphoblastic Lymphoma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jun 18, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Lymphoma Trial in United States (biological, drug, procedure)

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +3 more
  • BPX-501 dose 1
  • +5 more
  • Atlanta, Georgia
  • +7 more
Jul 10, 2022

Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in Seattle

Recruiting
  • Acute Biphenotypic Leukemia
  • +5 more
  • Dilanubicel
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
May 11, 2022

Related Donors Donating PBSC to a Family Member, Healthy Donors, Acute Myelogenous Leukemia Trial in United States (MGTA-145,

Terminated
  • Related Donors Donating PBSC to a Family Member
  • +4 more
  • MGTA-145
  • Plerixafor
  • Duarte, California
  • +7 more
Apr 13, 2022

Based Classification System of Newly Diagnosed Acute

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • Cytology Specimen Collection Procedure
  • Laboratory Biomarker Analysis
  • Birmingham, Alabama
  • +243 more
Mar 23, 2022

Leukemia, Precursor b-Cell Lymphoblastic Leukemia-Lymphoma, ACUTE LYMPHOBLASTIC LEUKEMIA Trial in Worldwide (inotuzumab

Active, not recruiting
  • Leukemia
  • +2 more
  • inotuzumab ozogamicin-dose level 2
  • Inotuzumab ozogamicin-dose level 1
  • Los Angeles, California
  • +45 more
Mar 9, 2022

Cancer, Acute Lymphoblastic Leukemia, Lymphoma Trial in Seattle (Promoting Resilience In Stress Management (PRISM))

Completed
  • Cancer
  • +6 more
  • Promoting Resilience In Stress Management (PRISM)
  • Seattle, Washington
    Seattle Children's Hospital
Jan 28, 2022

Hematologic Malignancy, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Canada, United States (CPX-351)

Completed
  • Hematologic Malignancy
  • +4 more
  • Washington, District of Columbia
  • +12 more
Jul 20, 2021

Acute Lymphoblastic Leukemia, Childhood B Acute Lymphoblastic Leukemia Trial in Worldwide (3-Dimensional Conformal Radiation

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • Childhood B Acute Lymphoblastic Leukemia
  • 3-Dimensional Conformal Radiation Therapy
  • +10 more
  • Birmingham, Alabama
  • +235 more
Jun 11, 2021

Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia, Childhood B Acute Lymphoblastic Leukemia Trial in Worldwide

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • +2 more
  • Birmingham, Alabama
  • +233 more
Apr 2, 2021